← SynDRA
CEFPIRAMIDE
SynDRA canonical compound SYN0023465 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | bacterial cell wall synthesis inhibitor |
|---|
| Indication | gram-negative bacterial infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
- dacA
- dacB
- dacC
- ftsI
- mrcA
- mrcB
- mrdA
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- mrcA INHIBITOR
- mrcB INHIBITOR
- dacC INHIBITOR
- mrdA INHIBITOR
- ftsI INHIBITOR
- dacA INHIBITOR
- dacB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ADORA1
- HRH3
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HTR1A
- HRH2
- ADORA2A
- HRH1
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01D · OTHER BETA-LACTAM ANTIBACTERIALS
Cross-references
Synonyms
- CEFPIRAMIDE SODIUM
- cefpiramide sodium
- Cefpiramida
- NSC-759869
- WY-44,635
- WY-44635
- Cefpiramido
- Cefpiramidum
- WY 44635
- Cefpiramide [USAN:INN]
- Cefpiramido [INN-Spanish]
- Cefpiramidum [INN-Latin]
- WY44,635
- Cefpiramide (USP/INN)
- Cefpiramide acid
- WY 44,635
- CHEBI:59213
- P936YA152N
- NSC 759869
- NCGC00167444-01
- SM-1652
- UNII-P936YA152N
- Cefpiramide [USAN:USP:INN]
- CEFPIRAMIDE [MI]
- CEFPIRAMIDE [INN]
- CEFPIRAMIDE [USAN]
- CEFPIRAMIDE [MART.]
- SCHEMBL49253
- CEFPIRAMIDE [USP-RS]
- CEFPIRAMIDE [WHO-DD]
- CHEMBL1201204
- DTXSID6046630
- GTPL12027
- CEFPIRAMIDE [USP IMPURITY]
- HMS3715H12
- HY-B1354
- ZINC4215257
- Tox21_112448
Look up CEFPIRAMIDE in the interactive SynDRA portal →